Elena Delbusto
Psychiatry · Haverford, PANPI 1154541712
Payments from drug & device makers
Across 280 payments — averaging $23.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$993
- AbbVie$827
- Johnson & Johnson$524
- Otsuka America Pharmaceutical, Inc.$427
- Jazz Pharmaceuticals Inc.$413
- Axsome Therapeutics, Inc.$396
- plus $3K from 25 others
What the payments were for
- Food & beverage$6,687100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 41 | $993 |
| AbbVie(2 entities) | 44 | $827 |
| Johnson & Johnson | 13 | $524 |
| Otsuka America Pharmaceutical, Inc. | 21 | $427 |
| Jazz Pharmaceuticals Inc. | 9 | $413 |
| Axsome Therapeutics, Inc. | 15 | $396 |
| Neurocrine Biosciences, Inc. | 16 | $375 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $324 |
| Harmony Biosciences LLC | 11 | $318 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $291 |
| Indivior Inc. | 7 | $219 |
| Lundbeck LLC | 10 | $207 |
| Eisai Inc. | 7 | $156 |
| Teva Pharmaceuticals USA, Inc. | 7 | $140 |
| Alkermes, Inc. | 6 | $140 |
| Bausch Health US, LLC | 7 | $139 |
| Braeburn Inc. | 6 | $125 |
| Collegium Pharmaceutical, Inc. | 5 | $92 |
| Almatica Pharma LLC | 3 | $80 |
| Supernus Pharmaceuticals, Inc. | 4 | $70 |
| EMD Serono, Inc. | 4 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| Idorsia Pharmaceuticals US Inc | 3 | $52 |
| Corium, LLC | 2 | $48 |
| Sage Therapeutics, LLC | 2 | $41 |
| Merck | 2 | $36 |
| Tris Pharma Inc | 2 | $33 |
| MDD US Operations, LLC | 1 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Avanir Pharmaceuticals, Inc. | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,694 in reported general payments places this provider in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $3,688 |
| Quetiapine Fumarate | 24 | $363 |
| Duloxetine Hcl | 40 | $169 |
| Propranolol Hcl | 25 | $153 |
| Gabapentin | 17 | $116 |
| Eszopiclone | 12 | $77 |
| Trazodone Hcl | 19 | $56 |
| Clonazepam | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Indivior Inc.Suboxone | $219 | $3,68812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Haverford
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.